Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

HKG:0460 Revenue

Sihuan Pharmaceutical Holdings Group had revenue of 1.16B CNY in the half year ending June 30, 2026, with 22.27% growth. This brings the company's total for the last twelve months to 2.63B, up 25.52% year-over-year. In the year 2025, Sihuan Pharmaceutical Holdings Group had annual revenue of 2.62B with 37.71% growth. That makes Sihuan Pharmaceutical Holdings Group the 12,797th largest company in the world by revenue and 766th in Hong Kong.

• Revenue (ttm): 2.63B CNY
• Revenue Growth: +25.52%
• P/S Ratio: 2.15
• Revenue / Employee: 970.88K CNY
• Employees: 2,712
• Market Cap: 6.52B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Medical Aesthetic Products 1.49B 55.5%
• Generic Medicine 956.32M 35.8%
• Innovative Medicine and Other Medicine 232.42M 8.7%

By Geography

Chart

• Mainland China 2.60B 99.5%
• United States of America 13.10M 0.5%
• Others 342.00K 0.0%

Fiscal year ended Dec 31, 2025 See the full HKG:0460 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.62B	716.90M	37.71%
Dec 31, 2024	1.90B	40.57M	2.18%
Dec 31, 2023	1.86B	-320.65M	-14.70%
Dec 31, 2022	2.18B	-857.20M	-28.21%
Dec 31, 2021	3.04B	574.17M	23.30%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 29, 2026

Data Sources Report a data error